These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 6089299)
41. [Treatment of paracoccidioidomycosis and histoplasmosis by oral itraconazole]. Negroni R; Palmieri OJ; Chá Torea JC Medicina (B Aires); 1987; 47(5):505-8. PubMed ID: 2849706 [No Abstract] [Full Text] [Related]
42. Paracoccidioidal infection in the wife of a patient with paracoccidioidomycosis. Conti-Díaz IA; Calegari L; Peña de Pereyra M; Casserone S; Fernández JJ; Scorza L Sabouraudia; 1979 Jun; 17(2):139-44. PubMed ID: 120614 [TBL] [Abstract][Full Text] [Related]
43. [Laboratory evolutive aspects of children under paracoccidioidomycosis treatment]. Nogueira MG; Andrade GM; Tonelli E; Diniz SN; Goes AM; Cisalpino PS Rev Soc Bras Med Trop; 2006; 39(5):478-83. PubMed ID: 17160327 [TBL] [Abstract][Full Text] [Related]
44. Adrenal function in paracoccidioidomycosis: a prospective study in patients before and after ketoconazole therapy. Abad A; Gomez I; Velez P; Restrepo A Infection; 1986; 14(1):22-6. PubMed ID: 3007365 [TBL] [Abstract][Full Text] [Related]
45. Advances and challenges in paracoccidioidomycosis serology caused by Paracoccidioides species complex: an update. da Silva JF; de Oliveira HC; Marcos CM; Assato PA; Fusco-Almeida AM; Mendes-Giannini MJS Diagn Microbiol Infect Dis; 2016 Jan; 84(1):87-94. PubMed ID: 26494541 [TBL] [Abstract][Full Text] [Related]
46. Antibody response to the 43 kDa glycoprotein of Paracoccidioides brasiliensis as a marker for the evaluation of patients under treatment. Giannini MJ; Bueno JP; Shikanai-Yasuda MA; Stolf AM; Masuda A; Amato Neto V; Ferreira AW Am J Trop Med Hyg; 1990 Aug; 43(2):200-6. PubMed ID: 2389824 [TBL] [Abstract][Full Text] [Related]
47. [Characterization of Paracoccidioides brasiliensis antigens. Serological immunodiagnosis using western blotting]. Ortega G; Villanueva E; Pereira J; Salma N; de Albornoz MB Acta Cient Venez; 1992; 43(6):355-9. PubMed ID: 1343747 [TBL] [Abstract][Full Text] [Related]
48. Indirect fluorescent test for detection of anti-Paracoccidioides brasiliensis antibodies using coated bentonite particles as antigen. Chamma LG; Fábio WF; Bacchi MM; Franco MF Trans R Soc Trop Med Hyg; 1983; 77(2):181-4. PubMed ID: 6408769 [TBL] [Abstract][Full Text] [Related]
49. [Effect of phagocytosis in vitro on Paracoccidioides brasiliensis]. Restrepo A; Vélez H Sabouraudia; 1975 Mar; 13 Pt 1():10-21. PubMed ID: 1168372 [TBL] [Abstract][Full Text] [Related]
50. Effect of serum sample inactivation on the performance of latex agglutination test for paracoccidioidomycosis serodiagnosis. Silveira-Gomes F; Marques-da-Silva SH Mem Inst Oswaldo Cruz; 2012 Jun; 107(4):510-2. PubMed ID: 22666862 [TBL] [Abstract][Full Text] [Related]
51. IgE antibody response to the main antigenic component of Paracoccidioides brasiliensis in patients with paracoccidioidomycosis. Biselli PJ; Juvenale M; Mendes-Giannini MJ; Duarte AJ; Benardi G Med Mycol; 2001 Dec; 39(6):475-8. PubMed ID: 11798051 [TBL] [Abstract][Full Text] [Related]
52. Serum interleukin-18 and soluble tumour necrosis factor receptor 2 are associated with disease severity in patients with paracoccidioidomycosis. Corvino CL; Mamoni RL; Fagundes GZ; Blotta MH Clin Exp Immunol; 2007 Mar; 147(3):483-90. PubMed ID: 17302897 [TBL] [Abstract][Full Text] [Related]
53. Serological and antigenic profiles of clinical isolates of Paracoccidioides spp. from Central Western Brazil. Queiroz Júnior Lde P; de Camargo ZP; Tadano T; Rodrigues AM; Takarara DT; Gegembauer G; Araujo LM; Hahn RC Mycoses; 2014 Aug; 57(8):466-72. PubMed ID: 24635832 [TBL] [Abstract][Full Text] [Related]
54. Combined use of Paracoccidioides brasiliensis recombinant rPb27 and rPb40 antigens in an enzyme-linked immunosorbent assay for immunodiagnosis of paracoccidioidomycosis. Fernandes VC; Coitinho JB; Veloso JM; Araújo SA; Pedroso EP; Goes AM J Immunol Methods; 2011 Mar; 367(1-2):78-84. PubMed ID: 21354162 [TBL] [Abstract][Full Text] [Related]
55. Endemic oral paracoccidioidomycosis: clinical presentation, management, and outcomes. Barbosa de Paulo LF; Silva de Faria L; Francisco Durighetto A Int J Infect Dis; 2014 Feb; 19():109-10. PubMed ID: 24184392 [No Abstract] [Full Text] [Related]
56. Paracoccidioidomycosis and its etiologic agent Paracoccidioides brasiliensis. San-Blas G J Med Vet Mycol; 1993; 31(2):99-113. PubMed ID: 8509955 [TBL] [Abstract][Full Text] [Related]
57. Predictive value of serologic tests in the diagnosis and follow-up of patients with paracoccidioidomycosis. Cano LE; Restrepo A Rev Inst Med Trop Sao Paulo; 1987; 29(5):276-83. PubMed ID: 3136529 [No Abstract] [Full Text] [Related]
58. Serological diagnosis of paracoccidioidomycosis in HIV-coinfected patients. Bellissimo-Rodrigues F; Vitali LH; Martinez R Mem Inst Oswaldo Cruz; 2010 Nov; 105(7):904-7. PubMed ID: 21120361 [TBL] [Abstract][Full Text] [Related]
59. Additive effect of P10 immunization and chemotherapy in anergic mice challenged intratracheally with virulent yeasts of Paracoccidioides brasiliensis. Marques AF; da Silva MB; Juliano MA; Munhõz JE; Travassos LR; Taborda CP Microbes Infect; 2008 Oct; 10(12-13):1251-8. PubMed ID: 18694844 [TBL] [Abstract][Full Text] [Related]
60. Natural killer cell activity in experimental paracoccidioidomycosis of the Syrian hamster. Peraçoli MT; Fortes MR; Da Silva MF; Montenegro MR Rev Inst Med Trop Sao Paulo; 1995; 37(2):129-36. PubMed ID: 7481468 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]